NOAC Stroke-Protection Benefits in AF; Abrupt Spike in Early Thrombosis With HeartMate II LVAD; Cardiac Device Deactivation; CABG Trumps PCI for Survival in CAD Even Without Diabetes

The heartwire team

Disclosures

December 06, 2013

This feature requires the newest version of Flash. You can download it here.

For the week ending December 6, 2013, we discuss the following top cardiology news from heartwire:

•  'New' Oral Anticoagulant Stroke-Protection Benefits in AF Cut Across Subgroups in Meta-Analysis

•  Abrupt Spike in Early Thrombosis With HeartMate II LVAD

•  Cardiac Device Deactivation Remains a Much-Delayed (and Thorny) Topic

•  CABG Trumps PCI for Survival in CAD Even Without Diabetes

And also, in brief:

•  Few See Renewed Role for Rosiglitazone in Diabetes

•  JAMA Weighs In on CVD Guidance, Statins in Primary Prevention

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....